Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage.

Abstract:

:Aneurysmal subarachnoid hemorrhage (SAH) accounts for a significant percentage of morbidity and mortality among patients admitted to neurosurgical centers throughout the world. Even for individuals surviving beyond the initial presentation and intervention for aneurysmal SAH, the occurrence of cerebral vasospasm has the potential to induce a second tier of complications that can be just as devastating as the inciting event. However, despite numerous studies and some initial advancements in management, therapeutic modalities are limited to help prevent or treat this complex entity. Historically, the mainstay of treatment for cerebral vasospasm has been a combination of hypervolemia, hemodilution, and hypertension. In addition, other systemic therapies such as oral nimodipine, statins, and intravenous magnesium, as well as intensive glucose control, appear to have some promise, although they are limited at times by adverse effects. To avoid these adverse consequences and perhaps gain some modicum of efficacy, attempts have been made to use endovascular techniques to physically dilate vessels or to administer drugs directly to the site of action and thus avoid many of the untoward effects of systemic pharmacotherapy. Controversy still remains over the success of intraarterial therapy, the drugs or techniques to be used, and the best timing of this therapy. Based on the currently available literature, it is impossible to assess the most effective intraarterial therapy. Randomized controlled trials that can control for baseline factors and technical expertise are needed to provide more conclusive data. Clinical pharmacists should be actively involved in assisting interventional radiologists and neurosurgeons in providing safe and appropriate pharmacotherapy in this promising but controversial arena of intraarterial drug delivery.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Weant KA,Ramsey CN 3rd,Cook AM

doi

10.1592/phco.30.4.405

subject

Has Abstract

pub_date

2010-04-01 00:00:00

pages

405-17

issue

4

eissn

0277-0008

issn

1875-9114

pii

10.1592/phco.30.4.405

journal_volume

30

pub_type

杂志文章,评审
  • 1992 National Clinical Pharmacy Services Study.

    abstract:STUDY OBJECTIVE:To determine the extent of hospital-based clinical pharmacy services in 1992. DESIGN:National survey with trend comparison to 1989. SETTING:All 1597 United States acute care, general medical-surgical and pediatric hospitals with 50 or more licensed beds and one or more full-time pharmacists (43% of al...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Bond CA,Raehl CL,Pitterle ME

    更新日期:1994-05-01 00:00:00

  • Decreased methadone effect after ritonavir initiation.

    abstract::Combination antiretroviral therapy including protease inhibitors such as ritonavir has added significant potency to therapy for human immunodeficiency viral (HIV) infection as well as substantial drug-drug interactions. Methadone metabolism is affected by cytochrome P450 (CYP) 3A4 inhibitors or inducers. Because riton...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.1.93.34654

    authors: Geletko SM,Erickson AD

    更新日期:2000-01-01 00:00:00

  • Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States.

    abstract::The antiretroviral combination of emtricitabine-tenofovir disoproxil fumarate (FTC/TDF) was approved by the U.S. Food and Drug Administration for use as pre-exposure prophylaxis (PrEP) in individuals at high risk for acquiring human immunodeficiency virus (HIV) in July 2012. Since then, Centers for Disease Control and...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2240

    authors: Adams JL,Shelley K,Nicol MR

    更新日期:2019-04-01 00:00:00

  • Preparing clinical pharmacy scientists for careers in clinical/translational research: can we meet the challenge?: ACCP Research Affairs Committee Commentary.

    abstract::Developing clinical pharmacists' research skills and their ability to compete for extramural funding is an important component of the American College of Clinical Pharmacy's (ACCP) vision for pharmacists to play a prominent role in generating the new knowledge used to guide patient pharmacotherapy. Given the recent em...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1348

    authors: Parker RB,Ellingrod V,DiPiro JT,Bauman JL,Blouin RA,Welage LS

    更新日期:2013-12-01 00:00:00

  • Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.

    abstract::Infections caused by multidrug-resistant Acinetobacter baumannii have become a therapeutic challenge for clinicians worldwide. Although colistin and tigecycline have been successful in treating patients with these infections, these agents are not available on a worldwide basis. We describe four critically ill patients...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.11.1506

    authors: Lee NY,Wang CL,Chuang YC,Yu WL,Lee HC,Chang CM,Wang LR,Ko WC

    更新日期:2007-11-01 00:00:00

  • Deprescribing: An Application to Medication Management in Older Adults.

    abstract::Polypharmacy has been found to have potentially negative consequences for patients due to use of potentially inappropriate medications, as well as increased risk of drug interactions and adverse effects. Deprescribing has been proposed as a method of improving medication use throughout a patient's course of care. This...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1776

    authors: Bemben NM

    更新日期:2016-07-01 00:00:00

  • Evaluation and Treatment of Acute and Subacute Hearing Loss: A Review of Pharmacotherapy.

    abstract::Among various forms of hearing loss, there are acute (within 72 hrs) or subacute (weeks to months) presentations that may be reversible with early pharmacological intervention. The workup of a patient presenting with hypoacusia includes the usual history and physical examination in conjunction with an audiometric asse...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2044

    authors: Fazel MT,Jedlowski PM,Cravens RB Jr,Erstad BL

    更新日期:2017-12-01 00:00:00

  • Target drug programs and medication use evaluation.

    abstract::Target drug programs and medication use evaluations are activities that are undertaken to improve the correct use of drugs. These programs should focus on inappropriate drug use, drug use problems, optimizing use of drugs, and improving the level of patient care. To monitor the effects of the programs, several types o...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.16.322s.35014

    authors: Hekster YA

    更新日期:2000-10-01 00:00:00

  • Tissue plasminogen activator: an evaluation of clinical efficacy in acute myocardial infarction.

    abstract::Recombinant tissue plasminogen activator (t-PA) is a synthetic fibrinolytic protein which activates plasminogen or converts plasminogen to plasmin specifically in the presence of fibrin. With its "clot-selectivity", t-PA is capable of lysing clots without having a significant effect on circulating plasminogen. In cont...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1987.tb04035.x

    authors: Rogers SD,Riemersma LB,Clements SD

    更新日期:1987-01-01 00:00:00

  • Intravenous amiodarone for conversion of atrial fibrillation: misled by meta-analysis?

    abstract::Therapeutic goals for atrial fibrillation (AF) include ventricular rate control, stroke prevention, conversion to normal sinus rhythm, and maintenance of normal sinus rhythm. The optimal strategy of rate versus rhythm control for acute management of patients with AF is a continuing debate. However, selected patients m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.8.792.36065

    authors: Slavik RS,Zed PJ

    更新日期:2004-06-01 00:00:00

  • Torsades de pointes associated with fluoroquinolones.

    abstract::Recent attention has been called to the interpretation of studies of antiinfective agents demonstrating effects on the QTc interval. It seems that the effects of many of these agents on the QTc interval are small, but in some patient populations, these drugs may cause morbidity and mortality related to TdP. It would b...

    journal_title:Pharmacotherapy

    pub_type: 评论,杂志文章

    doi:10.1592/phco.22.8.663.33201

    authors: Owens RC Jr,Ambrose PG

    更新日期:2002-05-01 00:00:00

  • The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy.

    abstract::Two analyses were conducted to compare the cost-effectiveness of different intravenous immunoglobulin (IGIV) formulations: IGIV purified by caprylate precipitation and chromatography (IGIV-C) and IGIV manufactured by an older solvent-detergent method (IGIV-S/D). The results indicated that IGIV-C is associated with cos...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.2005.25.11part2.94S

    authors: Mahadevia PJ

    更新日期:2005-11-01 00:00:00

  • Clinical pharmacology of recombinant human erythropoietin (r-HuEPO).

    abstract::Recombinant human erythropoietin reverses the severe anemia associated with end-stage renal disease. Mean half-life values after a single intravenous bolus dose range from 4-13 hours. Renal clearance is not a significant route of elimination. Dosing schedules in chronic renal failure involve a single intravenous bolus...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Flaharty KK

    更新日期:1990-03-01 00:00:00

  • Simvastatin-associated memory loss.

    abstract::The statins are widely used to treat dyslipidemias. They are generally associated with mild adverse effects, but rarely, more serious reactions may occur. A 51-year-old man experienced delayed-onset, progressive memory loss while receiving simvastatin for hypercholesterolemia. His therapy was switched to pravastatin, ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.7.767.34577

    authors: Orsi A,Sherman O,Woldeselassie Z

    更新日期:2001-06-01 00:00:00

  • Susceptibility testing of the polymyxins: where are we now?

    abstract::Antimicrobial susceptibility testing for the polymyxins-colistin and polymyxin B-is fraught with technical challenges. Key among these is the propensity of the polymyxins to adsorb to polystyrene, a material often used for in vitro minimum inhibitory concentration testing devices. This effect may be mitigated by the a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1505

    authors: Humphries RM

    更新日期:2015-01-01 00:00:00

  • Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery.

    abstract:STUDY OBJECTIVES:To compare the cost-effectiveness of intravenous plus oral amiodarone, atrial septal pacing, and both strategies combined to prevent atrial fibrillation after open heart surgery. Secondary objectives were to compare the cost-effectiveness of amiodarone versus no amiodarone and of pacing versus no pacin...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.24.11.1013.36132

    authors: Reddy P,Kalus JS,Caron MF,Horowitz S,Karapanos A,Coleman CI,Kluger J,White CM

    更新日期:2004-08-01 00:00:00

  • Immune-mediated coagulopathy: a case report.

    abstract::Surgical hemostasis may be achieved by using a number of physical, chemical, or biologic methods. One such method is with topical thrombin; however, one member of that class of drugs, bovine-derived thrombin, is associated with potentially serious consequences such as development of immune-mediated coagulopathy. This ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.pt2.13S

    authors: Naoum JJ

    更新日期:2009-07-01 00:00:00

  • Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.

    abstract:STUDY OBJECTIVES:To determine the effects of atorvastatin on low-density lipoprotein cholesterol (LDL) particle size and C-reactive protein (CRP) concentrations in patients undergoing long-term hemodialysis. Another objective was to compare the effects of atorvastatin on lipoprotein profiles as determined by direct ver...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.25.3.335.61599

    authors: Dornbrook-Lavender KA,Joy MS,Denu-Ciocca CJ,Chin H,Hogan SL,Pieper JA

    更新日期:2005-03-01 00:00:00

  • Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy.

    abstract::Buspirone is the first of a new class of anxioselective agents, the azaspirodecanediones. It achieves peak serum concentrations within one hour and has a serum half-life of 2 to 5 hours. Animal studies have suggested antianxiety activity and the absence of abuse potential. Buspirone is both a dopamine agonist and anta...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1984.tb03385.x

    authors: Goldberg HL

    更新日期:1984-11-01 00:00:00

  • Evaluation of the half-life of intravenous human cytomegalovirus immune globulin in patients receiving partially mismatched related donor bone marrow transplantation.

    abstract:STUDY OBJECTIVE:To evaluate the pharmacokinetics and use of intravenous human cytomegalovirus immune globulin (CytoGam) in allogeneic bone marrow transplantation (BMT). DESIGN:Prospective, nonrandomized, nonblinded, single-center study. SETTING:University teaching hospital. PATIENTS:Five consecutive patients with he...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.15.1175.34592

    authors: DeRienzo SY,Chiang KY,O'Neal WM,Godder K,Abhyankar S,Christiansen NP,Bridges KD,Henslee-Downey PJ

    更新日期:2000-10-01 00:00:00

  • Severe hypoglycemia from Helicobacter pylori triple-drug therapy and insulin detemir drug interaction.

    abstract::Two drugs commonly used in triple-drug therapy for treatment of a Helicobacter pylori infection, clarithromycin and omeprazole, have rarely been associated with hypoglycemia when given alone. No documented interactions between H. pylori treatment with clarithromycin, amoxicillin, and omeprazole and insulin detemir hav...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1228

    authors: Otsuka SH

    更新日期:2013-04-01 00:00:00

  • Symptomatic cardiotoxicity associated with 5-fluorouracil.

    abstract::A prospective cohort study was conducted in 35 hospitals with oncology units to determine the incidence of symptomatic cardiotoxicity in patients receiving continuous infusions of 5-fluorouracil (5-FU), and to identify risk factors that could contribute to the development of 5-FU-associated cardiotoxicity. A sample of...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Meyer CC,Calis KA,Burke LB,Walawander CA,Grasela TH

    更新日期:1997-07-01 00:00:00

  • Use of novel antipsychotic drugs.

    abstract::The atypical antipsychotic agents clozapine and risperidone bring new insight into the care and treatment of patients with schizophrenia. Since their introduction, several names (e.g., novel, atypical, serotonergic-dopaminergic antagonist) have been used to describe the nature of these compounds. The agents are unique...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Raleigh F

    更新日期:1996-11-01 00:00:00

  • Clinical and economic burden of opioid use for postsurgical pain: focus on ventilatory impairment and ileus.

    abstract::Opioid-related adverse drug events (ORADEs) can have a significant impact on patient recovery after surgery. This review investigates the impact of two ORADEs, respiratory depression and postoperative ileus (POI), on clinical and economic outcomes. Opioid-induced ventilatory impairment is a potentially serious ORADE t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.2012.01178.x

    authors: Barletta JF

    更新日期:2012-09-01 00:00:00

  • Acute hepatic failure associated with oral minocycline: a case report.

    abstract::A 39-year-old woman was evaluated for possible liver transplantation due to rapidly developing hepatic failure 4 weeks after initiation of oral minocycline 100 mg twice a day for the treatment of acne. The patient developed a maculopapular rash, malaise, fever, nausea, and vomiting 2 weeks prior to admission to the ho...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Min DI,Burke PA,Lewis WD,Jenkins RL

    更新日期:1992-01-01 00:00:00

  • Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.

    abstract:STUDY OBJECTIVE:To assess the reproducibility of Naranjo Adverse Drug Reaction Probability Scale (APS) scores in published case reports. DESIGN:Reliability analysis. MEASUREMENTS AND MAIN RESULTS:Randomly selected case reports using the APS were identified from the Web of Science database. The APS scores were blinded...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1496

    authors: Liang R,Borgundvaag B,McIntyre M,Thwaites C,Ragan K,Wyllie A

    更新日期:2014-11-01 00:00:00

  • Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.

    abstract::Methotrexate, administered for treatment of pediatric and adult malignancies, is a direct renal toxin, which can lead to renal dysfunction, decreased methotrexate clearance, elevated methotrexate concentrations, and systemic toxicity. Although plasma methotrexate concentrations have been shown to decline precipitously...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.30.1.111

    authors: Vilay AM,Mueller BA,Haines H,Alten JA,Askenazi DJ

    更新日期:2010-01-01 00:00:00

  • Insights into mechanisms of cisplatin resistance and potential for its clinical reversal.

    abstract::Cisplatin in combination with other cytotoxic agents is the backbone for a potential cure of testicular germ cell neoplasms and is a critical factor in the substantial activity observed in the treatment of small cell lung cancer, bladder cancer, and ovarian germ cell tumors. Resistance to cisplatin at the onset of tre...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Gosland M,Lum B,Schimmelpfennig J,Baker J,Doukas M

    更新日期:1996-01-01 00:00:00

  • Amphotericin B-associated hyperbilirubinemia: case report and review of the literature.

    abstract::A 53-year-old woman with an intraabdominal infection secondary to Candida albicans experienced hyperbilirubinemia after receiving amphotericin B in two different formulations--amphotericin B deoxycholate and amphotericin B lipid complex. Only a few case reports of amphotericin B-induced hyperbilirubinemia have been do...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.7.1011

    authors: Olin JL,Spooner LM

    更新日期:2006-07-01 00:00:00

  • Viral infectivity of albumin and plasma protein fraction.

    abstract::Original research, reviews, and case reports discussing viral infectivity of blood- and plasma-derived products were reviewed to determine the potential viral infectivity of human serum albumin (HSA) and plasma protein fraction (PPF). Data concerning viral infectivity viral screening and inactivation procedures, and v...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Erstad BL

    更新日期:1996-11-01 00:00:00